Efgartigimod alfa

Name: Efgartigimod alfa
Brand: TargetMol
SKU: T9901A-479
Rating: 4.5 (1 reviews)

Copy Product Info

🥰Excellent

Synonyms:

Catalog No. T9901A-479 Copy Product Info

🥰Excellent

Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.

Efgartigimod alfa

Cas No. 1821402-21-4

Pack Size	Price	USA Stock	Global Stock
1 mg	$336	4-6 weeks	4-6 weeks
5 mg	$863	4-6 weeks	4-6 weeks
10 mg	$1,360	4-6 weeks	4-6 weeks

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Resource Download

Instruction Manual of Inhibitory Antibody

Product Introduction

Bioactivity

Description	Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.
Application	ELISA FACS Functional assay
Antibody Type	Monoclonal
Formulation	Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin	<1.0 EU/mg